dc.contributor |
University of Aberdeen.Medical Sciences |
|
dc.contributor |
University of Aberdeen.Medicine, Medical Sciences & Nutrition |
|
dc.contributor |
University of Aberdeen.Applied Medicine |
|
dc.contributor |
University of Aberdeen.Clinical Medicine |
|
dc.contributor |
University of Aberdeen.Medical Sciences - Cardiovascular Group |
|
dc.contributor |
University of Aberdeen.Institute of Medical Sciences |
|
dc.creator |
Morrow, Gael B |
|
dc.creator |
Carlier, Molly S A |
|
dc.creator |
Dasgupta, Sruti |
|
dc.creator |
Craigen, Fiona B |
|
dc.creator |
Mutch, Nicola J |
|
dc.creator |
Curry, Nicola |
|
dc.date |
2021-02-24T12:48:01Z |
|
dc.date |
2021-02-24T12:48:01Z |
|
dc.date |
2021-02-22 |
|
dc.date.accessioned |
2022-05-24T06:08:49Z |
|
dc.date.available |
2022-05-24T06:08:49Z |
|
dc.identifier |
Morrow , G B , Carlier , M S A , Dasgupta , S , Craigen , F B , Mutch , N J & Curry , N 2021 , ' Fibrinogen Replacement Therapy for Traumatic Coagulopathy : Does the Fibrinogen Source Matter? ' , International Journal of Molecular Sciences , vol. 22 , no. 4 , 2185 . https://doi.org/10.3390/ijms22042185 |
|
dc.identifier |
1422-0067 |
|
dc.identifier |
PURE: 188459947 |
|
dc.identifier |
PURE UUID: 4dd7ba30-128f-411c-881c-b2ca64e8fc94 |
|
dc.identifier |
Bibtex: ijms22042185 |
|
dc.identifier |
Scopus: 85100912175 |
|
dc.identifier |
WOS: 000623846900001 |
|
dc.identifier |
PubMed: 33671748 |
|
dc.identifier |
PubMedCentral: PMC7926643 |
|
dc.identifier |
https://hdl.handle.net/2164/15919 |
|
dc.identifier |
https://doi.org/10.3390/ijms22042185 |
|
dc.identifier |
http://www.scopus.com/inward/record.url?scp=85100912175&partnerID=8YFLogxK |
|
dc.identifier |
22 |
|
dc.identifier |
4 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/117803 |
|
dc.description |
Funding: This work was supported by an NIHR programme grant for applied research; PGfAR01590; “Traumatic coagulopathy and massive transfusion: improving outcomes and saving blood”. |
|
dc.description |
Peer reviewed |
|
dc.description |
Publisher PDF |
|
dc.format |
15 |
|
dc.format |
application/pdf |
|
dc.language |
eng |
|
dc.relation |
International Journal of Molecular Sciences |
|
dc.rights |
Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and con‐ ditions of the Creative Commons Attribution (CC BY) license (http://crea‐ tivecommons.org/licenses/by/4.0/) |
|
dc.subject |
fibrinogen |
|
dc.subject |
cryoprecipitate |
|
dc.subject |
trauma coagulopathy |
|
dc.subject |
2‐antiplasmin |
|
dc.subject |
Factor XIII |
|
dc.subject |
Fibrinogen |
|
dc.subject |
Trauma coagulopathy |
|
dc.subject |
α2‐antiplasmin |
|
dc.subject |
Cryoprecipitate |
|
dc.subject |
(2)-antiplasmin |
|
dc.subject |
α |
|
dc.subject |
factor XIII |
|
dc.subject |
R Medicine |
|
dc.subject |
Molecular Biology |
|
dc.subject |
Spectroscopy |
|
dc.subject |
Catalysis |
|
dc.subject |
Inorganic Chemistry |
|
dc.subject |
Computer Science Applications |
|
dc.subject |
Physical and Theoretical Chemistry |
|
dc.subject |
Organic Chemistry |
|
dc.subject |
R |
|
dc.title |
Fibrinogen Replacement Therapy for Traumatic Coagulopathy : Does the Fibrinogen Source Matter? |
|
dc.type |
Journal article |
|